Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 23656708)

1.

Individualized fracture risk assessment: progresses and challenges.

Nguyen TV, Center JR, Eisman JA.

Curr Opin Rheumatol. 2013 Jul;25(4):532-41. doi: 10.1097/BOR.0b013e328361ff8c. Review.

PMID:
23656708
2.

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).

Kanis JA, Johansson H, Oden A, McCloskey EV.

Osteoporos Int. 2011 Aug;22(8):2347-55. doi: 10.1007/s00198-010-1474-0. Epub 2011 Feb 2. Erratum in: Osteoporos Int. 2011 Aug;22(8):2357-8.

PMID:
21287148
3.

Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.

Ström O, Jönsson B, Kanis JA.

Osteoporos Int. 2013 Apr;24(4):1491-502. doi: 10.1007/s00198-012-2115-6. Epub 2012 Dec 7.

PMID:
23224141
4.

Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.

Reginster JY.

Drugs. 2011 Jan 1;71(1):65-78. doi: 10.2165/11587570-000000000-00000. Review.

PMID:
21175240
5.

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD; CaMos Research Group.

Osteoporos Int. 2011 Mar;22(3):829-37. doi: 10.1007/s00198-010-1465-1. Epub 2010 Dec 16.

PMID:
21161508
6.

Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.

McCloskey EV, Johansson H, Oden A, Austin M, Siris E, Wang A, Lewiecki EM, Lorenc R, Libanati C, Kanis JA.

J Bone Miner Res. 2012 Jul;27(7):1480-6. doi: 10.1002/jbmr.1606.

PMID:
22431426
7.

Evaluation of the FRAX and Garvan fracture risk calculators in older women.

Bolland MJ, Siu AT, Mason BH, Horne AM, Ames RW, Grey AB, Gamble GD, Reid IR.

J Bone Miner Res. 2011 Feb;26(2):420-7. doi: 10.1002/jbmr.215.

PMID:
20721930
8.

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis.

Reginster JY, Kaufman JM, Goemaere S, Devogelaer JP, Benhamou CL, Felsenberg D, Diaz-Curiel M, Brandi ML, Badurski J, Wark J, Balogh A, Bruyère O, Roux C.

Osteoporos Int. 2012 Mar;23(3):1115-22. doi: 10.1007/s00198-011-1847-z. Epub 2011 Nov 29.

9.

Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.

Scotland G, Waugh N, Royle P, McNamee P, Henderson R, Hollick R.

Pharmacoeconomics. 2011 Nov;29(11):951-61. doi: 10.2165/11589310-000000000-00000. Review.

PMID:
21854080
10.

Does osteoporosis therapy invalidate FRAX for fracture prediction?

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Bone Miner Res. 2012 Jun;27(6):1243-51. doi: 10.1002/jbmr.1582.

PMID:
22392538
11.

Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.

Donaldson MG, Palermo L, Ensrud KE, Hochberg MC, Schousboe JT, Cummings SR.

J Bone Miner Res. 2012 Aug;27(8):1804-10. doi: 10.1002/jbmr.1625.

PMID:
22492479
12.

Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Bone Miner Res. 2010 Nov;25(11):2350-8. doi: 10.1002/jbmr.123.

PMID:
20499367
13.

Development and use of FRAX in osteoporosis.

Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F.

Osteoporos Int. 2010 Jun;21 Suppl 2:S407-13. doi: 10.1007/s00198-010-1253-y. Epub 2010 May 13. Review.

PMID:
20464374
14.

[Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].

Naranjo A, Ojeda-Bruno S, Francisco-Hernández F, Erausquin C, Rúa-Figueroa I, Rodríguez-Lozano C.

Med Clin (Barc). 2011 Mar 19;136(7):290-2. doi: 10.1016/j.medcli.2010.06.028. Epub 2010 Dec 24. Spanish.

PMID:
21185575
15.

Predictive value of FRAX for fracture in obese older women.

Premaor M, Parker RA, Cummings S, Ensrud K, Cauley JA, Lui LY, Hillier T, Compston J; Study of Osteoporotic Fractures (SOF) Research Group.

J Bone Miner Res. 2013 Jan;28(1):188-95. doi: 10.1002/jbmr.1729.

16.

Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Borgström F, Ström O, Kleman M, McCloskey E, Johansson H, Odén A, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):955-65. doi: 10.1007/s00198-010-1291-5. Epub 2010 Jun 8.

PMID:
20532482
17.

Assessment of individual fracture risk: FRAX and beyond.

van den Bergh JP, van Geel TA, Lems WF, Geusens PP.

Curr Osteoporos Rep. 2010 Sep;8(3):131-7. doi: 10.1007/s11914-010-0022-3.

18.

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.

Freemantle N, Cooper C, Diez-Perez A, Gitlin M, Radcliffe H, Shepherd S, Roux C.

Osteoporos Int. 2013 Jan;24(1):209-17. doi: 10.1007/s00198-012-2068-9. Epub 2012 Jul 26.

19.

Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts.

Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley DA, Ioannidis G, Josse RG, Kovacs CS, Towheed T, Kaiser S, Olszynski WP, Prior JC, Jamal S, Kreiger N, Goltzman D; Canadian Multicentre Osteoporosis Study Research Group.

Osteoporos Int. 2011 Jun;22(6):1873-83. doi: 10.1007/s00198-010-1445-5. Epub 2010 Oct 22.

PMID:
20967422
20.

Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.

Tamaki J, Iki M, Kadowaki E, Sato Y, Kajita E, Kagamimori S, Kagawa Y, Yoneshima H.

Osteoporos Int. 2011 Dec;22(12):3037-45. doi: 10.1007/s00198-011-1537-x. Epub 2011 Jan 29.

PMID:
21279504
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk